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Regarding “A prospective study of subclinical
myocardial damage in endovascular versus open
repair of infrarenal abdominal aortic aneurysms”
We read with interest the recent article by Abraham et al.1
Perioperative cardiac events are the major cause of perioperative
morbidity and mortality in patients undergoing noncardiac vascu-
lar surgery due to symptomatic or asymptomatic coronary artery
disease (CAD). The incidence of myocardial infarction and cardiac
death can be as high as 28% in patients with CAD detected by
dobutamine stress echocardiography, whereas myocardial ischemia
detected by continuous electrocardiographic recording is more
than 39%.2,3
In their article, Abraham et al describe a cohort of 149 patients
who underwent open (n  36) or endovascular (n  113) elective
infrarenal abdominal aortic aneurysm repair. Their findings of myo-
cardial ischemia in 25% of patients in the open group are in accordance
with these data. For endovascular treatment, there was no information
on postoperative troponin T release. Abraham et al concluded that
subclinical myocardial damage is probably significantly less in patients
treated endovascularly compared with patients who undergo open
repair. However, this conclusion can be questioned.
First, as the authors discuss, there is a possibility of selection bias.
Apart from differences in vascular anatomy, there are a number of risk
factors associated with perioperative cardiac events, defined by the
Revised Cardiac Risk Index, and also cardioprotective medication.
The Revised Cardiac Risk Index4 includes several risk factors, ie, type
of surgery, history of ischemic heart disease, history of congestive
heart failure, history of cerebrovascular disease, preoperative treat-
ment with insulin, and preoperative serum creatinine. The rates of
major postoperative cardiac complications ranged from 0.5% to 11%
in patients with a score ranging from 0 to 3 or more factors. It would
therefore be interesting to know whether there was a difference in the
Revised Cardiac Risk Index score between endovascularly treated and
open-treated patients. The authors report that there was a difference
in the incidence of previous myocardial infarction. However, this is
only one of the factors included in the risk index.
Furthermore, medical therapy may influence outcome. Nowa-
days there is substantial evidence that high-risk vascular surgical pa-
tients receiving -blocker therapy have an improved outcome.5 Also,
recent publications suggest postoperative benefits of statin therapy.6,7
Because the reported study was a nonrandomized study, patients
undergoing endovascular treatment could have been selected on the
basis of their supposed increased cardiac risk related to previous
events. Therefore, it could well be that patients in the endovascular
treatment arm were more frequently receiving cardioprotective med-
ication.
Although the conclusion of the authors is very plausible, for a
more accurate comparison of cardiac outcome between endovas-
cular and open treatment of abdominal aortic repair in nonran-
domized studies, information on preoperative cardiac conditions,
including medication use, objective assessment of CAD, cardiac
risk factors, and stratification in risk indices, is of great importance.
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Reply
We thank Dr Schouten and colleagues for their comments on
our article. Their statement in the first paragraph, “For endovas-
cular treatment, there was no information on postoperative tropo-
nin T release,” is puzzling. The article clearly reports increases in
troponin T after endovascular abdominal aortic aneurysm (AAA)
repair in 9 (8%) of 109 patients compared with 8 (25%) of 32
patients after open AAA (P  .02).1 Because there was only one
patient with clinical myocardial ischemia in the open group and
there were none in the endovascular group, our major clinical
finding from the study was that there is biochemical evidence of
previously underestimated myocardial damage associated with
elective AAA repair regardless of the type of repair. This subclinical
damage is likely significantly less with endovascular than with open
repair. The finding, we believe, is relevant when deciding on the
method of AAA repair, even when the patient is considered low
risk.
Dr Schouten and colleagues raise the question of differences in
risk factors and cardioprotective medications between the endo-
vascular and open groups. We reported that there was no statisti-
cally significant difference between the groups with regard to risk
factors for ischemic heart disease except for a history of myocardial
infarction of 41% in the endovascular group compared with 22% in
the open group (P  .05). Such a difference should make the
endovascular group more likely to develop myocardial ischemia
rather than less likely compared with the open group. The Revised
Cardiac Risk Index, taking into account cardiac and noncardiac
factors, is one of many comorbidity severity scoring systems that
may be used. The Ad Hoc Committee for Standardized Reporting
Practices in Vascular Surgery2 states that “At least seven scoring
systems have been developed for assessing the relationship of
bundled clinical parameters as a measure of cardiac risk.” Although
it would be of interest to know whether there was a difference in
the Revised Cardiac Risk Index between the two groups, it is
impractical to analyze the data in multiple ways to fulfill the wishes
of all. The recent articles suggesting postoperative benefits of statin
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